Office of the Revisor of Statutes

HF 2768

Status in the House - 92nd Legislature (2021 - 2022)

Current bill text: As Introduced
Add HF2768 to MyBills
Version List

Companion: SF2678
Companion Text
Senate Search

Revisor number: 22-05495

Long Description

Further Committee Actions

House Research Summary
Fiscal Notes

Engrossments
Introduction PDF	Posted on 01/24/2022	Comparison Report: SF2678 As Introduced

Description

Pharmacists authorized to administer drugs through intramuscular or subcutaneous administration; and drug monitoring devices authorized.

01/31/2022	Introduction and first reading, referred to Health Finance and Policy pg. 7591 Intro
02/17/2022	Authors added Davids, Elkins, and Huot pg. 7827
02/28/2022	Author added Hausman pg. 7938
03/28/2022	Committee report, to adopt pg. 8467
03/28/2022	Second reading pg. 8572
05/18/2022	Referred to Chief Clerk for comparison with SF2678 pg. 13191
05/19/2022	Bills identical, SF substituted on General Register pg. 13198
05/19/2022	HF indefinitely postponed pg. 13198
	See Senate file in House SF2678

House Actions	Senate Actions
01/31/2022
Introduction and first reading, referred to Health Finance and Policy pg. 7591 Intro
02/17/2022
Authors added Davids, Elkins, and Huot pg. 7827
02/28/2022
Author added Hausman pg. 7938
03/28/2022
Committee report, to adopt pg. 8467 Second reading pg. 8572
05/18/2022
Referred to Chief Clerk for comparison with SF2678 pg. 13191
05/19/2022
Bills identical, SF substituted on General Register pg. 13198 HF indefinitely postponed pg. 13198
Final Actions
See Senate file in House SF2678